SSR1 and glioma: Thus, there is a prominent UPR activation profile that provides glioma cells/tumors with expanded ER protein-folding machinery and indications of increased translocon capacity (eg, high expression of TRAPα and Sec61α, Figure 1—Sec61α is considered a proto-oncogene responsive to ER stress [62]).